Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel L Aitken

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Transplantation and Cellular Therapy|August 28, 2021
American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell TransplantationMorgan Hakki, Samuel L Aitken, Lara Danziger-Isakov, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing <i>Escherichia coli</i> in Patients with Hematologic MalignancyGrace E Benanti, Anne Rain T Brown, Terri Lynn Shigle, et al.
Open Forum Infectious Diseases|June 10, 2026
Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient SettingJeffrey M Harrington, Jerod L Nagel, Samantha Sallerson, et al.
Pharmacotherapy|April 12, 2020
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position PaperEmily L Heil, Samuel L Aitken, David E Nix, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
A novel 2-step process for the management of inpatient beta-lactam allergy labelsRajan Ravikumar, Nonie S Arora, Rebecca Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2020
Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical OutcomesEduardo A Yepez Guevara, Samuel L Aitken, Adilene V Olvera, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort studyKady Phe, Ryan K Shields, Frank P Tverdek, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant PatientMaria F Mojica, Christopher P Ouellette, Amy Leber, et al.
Mbio|January 5, 2024
Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185Akito Kawai, William C Shropshire, Masahiro Suzuki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis EraJoseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Transplantation and Cellular Therapy|August 28, 2021
American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell TransplantationMorgan Hakki, Samuel L Aitken, Lara Danziger-Isakov, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing <i>Escherichia coli</i> in Patients with Hematologic MalignancyGrace E Benanti, Anne Rain T Brown, Terri Lynn Shigle, et al.
Open Forum Infectious Diseases|June 10, 2026
Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient SettingJeffrey M Harrington, Jerod L Nagel, Samantha Sallerson, et al.
Pharmacotherapy|April 12, 2020
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position PaperEmily L Heil, Samuel L Aitken, David E Nix, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
A novel 2-step process for the management of inpatient beta-lactam allergy labelsRajan Ravikumar, Nonie S Arora, Rebecca Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2020
Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical OutcomesEduardo A Yepez Guevara, Samuel L Aitken, Adilene V Olvera, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort studyKady Phe, Ryan K Shields, Frank P Tverdek, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant PatientMaria F Mojica, Christopher P Ouellette, Amy Leber, et al.
Mbio|January 5, 2024
Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185Akito Kawai, William C Shropshire, Masahiro Suzuki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis EraJoseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Pageof 11